1. Home
  2. Browse
  3. Substance use

52 open

Substance use funding

52 open opportunities tagged Substance use, across federal agencies and private foundations. Sorted by deadline.

Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R61/R33 Clinical Trial Optional)

PAR-25-158National Institutes of Health3 review criteria on fileagency framework

—

Community Engagement Evaluation and Data Coordination (CEED) Hub to Advance Data and Practice Transformation for Optimizing Oral Health for All (U01, Clinical Trial Not Allowed)

RFA-DE-27-001National Institutes of Health3 review criteria on file

—

DOJ FY 2026 Invited to Apply - National Integrated Ballistic Information (NIBIN) Modernization Program

O-BJA-2026-172648Bureau of Justice Assistance

—

Development of Interventions to Prevent and Treat Substance Use Disorders and Overdose (UG3/UH3 - Clinical Trial Optional)

PAR-25-446National Institutes of Health3 review criteria on fileagency framework

$3M

BJA FY 2026 Tribal Justice Training and Technical Assistance Program

O-BJA-2026-172727Bureau of Justice Assistance

$1.9M

HEAL Initiative: Non-addictive Analgesic Therapeutics Development [Small Molecules and Biologics] to Treat Pain (UG3/UH3 Clinical Trial Optional)

RFA-NS-27-007National Institutes of Health3 review criteria on file

—

Intervention Research to Improve Native American Health (R34 Clinical Trial Optional)

PAR-25-378National Institutes of Health3 review criteria on file

—

Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)

PAR-25-379National Institutes of Health3 review criteria on file

—

National Cooperative Drug/Device Discovery/Development Groups (NCDDG) for the Treatment of Mental Disorders (U19 Clinical Trial Optional)

PAR-25-353National Institutes of Health7 review criteria on file

—

OJJDP FY 2026 Juvenile Drug Treatment Court Program

O-OJJDP-2026-172741Office of Juvenile Justice Delinquency Prevention

$1M

BJA FY 2026 Veterans Treatment Court Program

O-BJA-2026-172714Bureau of Justice Assistance

$2.5M

OJJDP FY 2026 Community and Schools Youth Drug Prevention Program

O-OJJDP-2026-172734Office of Juvenile Justice Delinquency Prevention

$750k

HEAL Initiative: Whole Joint Health Program (R61/R33 Clinical Trial Required)

PAR-27-045National Institutes of Health

—

Population Assessment of Tobacco and Health (PATH) Study Biospecimen Access (X01)

PAR-24-027National Institutes of Health

—

BJA FY 2026 Adult Treatment Court Program

O-BJA-2026-172721Bureau of Justice Assistance

$2.5M

BJA FY 2026 Comprehensive Opioid, Stimulant, and Substance Use Program (COSSUP) Training and Technical Assistance (TTA)

O-BJA-2026-172724Bureau of Justice Assistance

$1M

BJA FY 2026 Edward Byrne Memorial Justice Assistance Grant (JAG) Program—Local Formula

O-BJA-2026-172705Bureau of Justice Assistance

$5.0M

Population Approaches to Reducing Alcohol-related Cancer Risk (R01 Clinical Trial Optional)

PAR-25-221National Institutes of Health3 review criteria on file

—

Screening, Brief Intervention and Referral to Treatment or Prevention (SBIRT/P) for alcohol, tobacco, and other drugs (ATOD) use and misuse in adult populations that experience health disparities (R01, Clinical Trial Required)

PAR-26-001National Institutes of Health3 review criteria on file

—

Causal Hypotheses on the Oral-Systemic Health Impacts of Human Behaviors among People with Chronic Conditions (U01 Clinical Trial Not Allowed)

PAR-27-057National Institutes of Health3 review criteria on fileagency framework

$500k

NIDA Mentored Clinical Scientist Development Program Award in Substance Use and Substance Use Disorder Research (K12 Clinical Trial Optional)

PAR-24-089National Institutes of Health5 review criteria on fileagency framework

$750k

Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R34 Clinical Trial Optional)

PAR-25-159National Institutes of Health3 review criteria on fileagency framework

—

Community-Based Participatory Research to Advance Data and Practice Transformation (ADAPT) for Optimizing Oral Health for All (UG3/UH3 Clinical Trial Optional)

PAR-27-015National Institutes of Health3 review criteria on file

$300k

Science Track Award for Research Transition (START) Program (R03, Clinical Trial Optional)

PAS-27-028National Institutes of Health3 review criteria on fileagency framework

—

D-START: Data Science Track Award for Research Transition (D/START) (R03-Clinical Trial Optional)

PAS-25-236National Institutes of Health3 review criteria on fileagency framework

—

OJJDP FY 2026 Opioid Affected Youth Initiative

O-OJJDP-2026-172748Office of Juvenile Justice Delinquency Prevention

$750k

Pilot Health Services and Economic Research on the Treatment of Drug, Alcohol, and Tobacco Use Disorders (R34 Clinical Trial Optional)

PAR-25-100National Institutes of Health3 review criteria on fileagency framework

—

OJJDP FY 2026 Family Treatment Court Program

O-OJJDP-2026-172738Office of Juvenile Justice Delinquency Prevention

$850k

OJJDP FY 2026 Mentoring for Youth Impacted by Opioids and Other Substance Use

O-OJJDP-2026-172743Office of Juvenile Justice Delinquency Prevention

$2M

OJJDP FY 2026 Expanding Youth Access to Community-Based Treatment

O-OJJDP-2026-172737Office of Juvenile Justice Delinquency Prevention

$650k

Chemical Countermeasures Research Program (CCRP) Initiative: Basic Research on The Deleterious Effects of Acute Exposure to Ultra-Potent Synthetic (UPS) Opioids (R01 Clinical Trial Not Allowed)

RFA-DA-26-034National Institutes of Health3 review criteria on fileagency framework

$300k

BJA FY 2026 Residential Substance Abuse Treatment for State Prisoners – Formula Grants Program

O-BJA-2026-172763Bureau of Justice Assistance

$2.2M

NIJ FY 2026 Research on Gender Dysphoria and Violent Crime

O-NIJ-2026-172802National Institute of Justice

$1M

Accelerating the Pace of Substance Use Research Using Existing Data (R21 Clinical Trial Not Allowed)

RFA-DA-26-056National Institutes of Health3 review criteria on fileagency framework

—

Accelerating the Pace of Substance Use Research Using Existing Data (R01 Clinical Trial Not Allowed)

RFA-DA-26-055National Institutes of Health3 review criteria on fileagency framework

—

HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed)

RFA-NS-25-023National Institutes of Health4 review criteria on file

$350k

HEAL Initiative: Integrative Management of chronic Pain and OUD for Whole Recovery (IMPOWR) - Building Engagement, Assistance, Capacity, Outreach, and Networks (BEACON) Center (U2C Clinical Trial Not Allowed)

RFA-DA-28-012National Institutes of Health

—

HEAL Initiative: Integrative Management of Chronic Pain and OUD for Whole Recovery (IMPOWR): Research Centers (RM1 Clinical Trial Required)

RFA-DA-28-011National Institutes of Health

—

Specialized Alcohol Research Centers (P50 Clinical trial Optional)

RFA-AA-28-001National Institutes of Health

$1.1M

Blueprint MedTech Translator (UG3/UH3 - Clinical Trial Optional)

PAR-25-383National Institutes of Health3 review criteria on file

—

High Priority HIV and Substance Use Research (R01 Clinical Trial Optional)

RFA-DA-25-024National Institutes of Health3 review criteria on fileagency framework

—

High Priority HIV and Substance Use Research (RM1 Clinical Trial Optional)

RFA-DA-25-060National Institutes of Health

$1.5M

Neural Ensembles & Used Substances (NExUS) Collaboratory: Building a Multimodal Inventory of Cell Ensembles Encoding the Effects of Addictive Substances (U01 Clinical Trial Not Allowed)

RFA-DA-28-013National Institutes of Health

—

Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research (U01 Clinical Trial Not Allowed)

PAR-25-248National Institutes of Health3 review criteria on file

—

HEAL Initiative: Translating Addiction Epidemiology, Prevention, Treatment, and Recovery Research into Practice (R61/R33 - Clinical Trial Optional)

RFA-DA-27-016National Institutes of Health3 review criteria on file

—

NIDA Animal Genomics Program (U01 Clinical Trial Not Allowed)

PAR-24-269National Institutes of Health3 review criteria on fileagency framework

—

Cutting-Edge Basic Research Awards (CEBRA) (R21 Clinical Trial Optional)

PAR-25-101National Institutes of Health3 review criteria on fileagency framework

$150k

Avant Garde/Avenir Awards for Investigators Conducting High Risk/High Reward Research on HIV and Substance Use (or Substance Use Disorders) (DP1 Clinical Trial Optional)

PAR-27-026National Institutes of Health7 review criteria on fileagency framework

—

Commercial Fishing Occupational Safety Research Cooperative Agreement (U01)

RFA-OH-22-005Centers for Disease Control and Prevention - ERAReview criteria on file

$975k

Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Clinical Trial Optional)

PAR-27-053National Institutes of Health

—

NIH Brain Development Cohorts (NBDC) and Population Assessment of Tobacco and Health (PATH) Study Biospecimen Access (X01 Clinical Trial Not Allowed)

PAR-27-051National Institutes of Health

—

Brain & Behavior Research Foundation — join our email list

Brain & Behavior Research Foundation

$100k
Rolling

Read the review criteria before you apply

A free account shows the review criteria on file and the announcement text where we hold it. The eligibility check, funded precedents and the Reviewer Scorecard are on Plus, $39 a month. No card required.

Create free accountBrowse all funders

Related subjects